Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

Although embryonic stem cells (ESCs) have been successfully derived from mice and rats, efforts to establish chimeric and germline-competent ESC lines in species beyond rodents have been unsuccessful.

The earliest days after fertilization, once a sperm cell meets an egg, are shrouded in scientific mystery. The process of how a humble single cell becomes an organism fascinates scientists across ...

For several years, researchers studied human embryonic stem cells (ESCs) to understand the unique features of these pluripotent cells, but on their own, they poorly resembled the complex structures ...

Between 1998 and 2009, research being conducted using human embryonic stem (hES) cells expanded primarily using private funds because of restrictions on the use of federal funds for such research.

Jennifer Zenker receives funding from NHMRC and Viertel Foundation. Most people have heard of stem cells. They are often described as “miracle” cells –ones that can grow into any other type of cell in ...

PUERTO VALLARTA, Mexico — In the world of regenerative medicine, a new type of stem cell is generating excitement among scientists, physicians, and patients alike: MUSE cells, short for Multilineage ...

Researchers have created a way to guide and control the development of stem cells into specific tissues and organs, opening the door to developing a means of one day tackling complex diseases like ...